Previous Close | $221.55 |
Intrinsic Value | $2,948.26 |
Upside potential | +1,231% |
Data is not available at this time.
Molina Healthcare, Inc. operates as a managed care organization specializing in government-sponsored healthcare programs, primarily Medicaid, Medicare, and Marketplace plans. The company serves low-income individuals and families, focusing on cost-effective care coordination and value-based reimbursement models. Molina differentiates itself through localized service delivery, leveraging its expertise in managing complex populations with chronic conditions. Its market position is strengthened by strategic partnerships with providers and state agencies, ensuring competitive access to government contracts. The company operates in a highly regulated sector where scale, operational efficiency, and compliance are critical to maintaining margins. Molina’s revenue is predominantly fee-based, tied to per-member-per-month premiums, with performance incentives tied to quality metrics. As Medicaid expansion and Medicare Advantage enrollment grow, Molina is well-positioned to capitalize on demographic and policy tailwinds.
Molina reported $40.65 billion in revenue for FY 2024, reflecting steady growth driven by membership gains and premium rate adjustments. Net income stood at $1.18 billion, with diluted EPS of $20.42, indicating robust profitability. Operating cash flow of $644 million underscores efficient working capital management, while capital expenditures of -$100 million suggest disciplined reinvestment. The company’s margin stability is supported by its focus on administrative cost containment and risk-adjusted pricing.
Molina’s earnings power is anchored in its ability to scale government-sponsored programs with predictable margins. The company’s capital efficiency is evident in its low capex intensity, allowing free cash flow generation to fund growth initiatives and debt reduction. With a capital-light model, Molina prioritizes return on invested capital through organic enrollment growth and selective market expansion.
Molina maintains a solid balance sheet with $4.66 billion in cash and equivalents against $3.12 billion in total debt, providing ample liquidity. The company’s leverage is manageable, supported by consistent cash flow generation. Regulatory capital requirements are met comfortably, ensuring operational flexibility in a dynamic reimbursement environment.
Molina’s growth is driven by Medicaid expansion and aging population trends, with revenue compounding annually. The company does not pay dividends, opting instead to reinvest cash flows into strategic acquisitions and technology upgrades. Membership growth and geographic diversification remain key priorities, supported by regulatory tailwinds in managed care.
Molina trades at a premium to peers, reflecting its strong execution and growth prospects. Investors price in sustained enrollment gains and margin stability, though regulatory risks remain a monitorable factor. The stock’s valuation aligns with its earnings trajectory and sector multiples.
Molina’s localized expertise and government-focused model provide durable competitive advantages. The outlook remains positive, with policy support for Medicaid and Medicare Advantage likely to sustain growth. Operational efficiency and compliance excellence position the company to navigate industry headwinds, though reimbursement pressures require ongoing vigilance.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |